VRNA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Verona Pharma PLC

Watchlist Manager

Watchlist

Price: 86 USD Market Closed

Market Cap: $7.4B

	Verona Pharma PLC NASDAQ:VRNA	UK
C	Carnival PLC NYSE:CUK	UK
	Vidrala SA OTC:VDRFF	ES
	Naspers Ltd OTC:NAPRF	ZA
	PubMatic Inc NASDAQ:PUBM	US
A	Allkem Ltd ASX:AKE	AU
L	Lumos Diagnostics Holdings Ltd ASX:LDX	AU
	Goldman Sachs Group Inc NYSE:GS	US
	DocMorris AG SIX:DOCM	CH
	Aero Energy Ltd F:J5B	CA
	Golar LNG Ltd NASDAQ:GLNG	BM
	Innospec Inc NASDAQ:IOSP	US
	Tips Industries Ltd NSE:TIPSINDLTD	IN
	Ballard Power Systems Inc TSX:BLDP	CA

Profitability Summary

Verona Pharma PLC's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

95%

Strong 3Y Average Gross Margin

62%

Negative Operating Margin

-25%

Negative 3Y Average Operating Margin

-5 165%

Operating Margin is Increasing

-16 022% > -25%

Negative Net Margin

-37%

Negative 3Y Average Net Margin

-4 261%

Net Margin is Increasing

-13 176% > -37%

Negative Free Cash Flow Margin

-33%

Negative 3Y Average Free Cash Flow Margin

-4 019%

Free Cash Flow Margin is Increasing

-11 122% > -33%

Negative ROE

-36%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-267%

ROIC is Increasing

-280% > -80%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.